<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484013</url>
  </required_header>
  <id_info>
    <org_study_id>PEVAR-PRO/141/OSR</org_study_id>
    <nct_id>NCT03484013</nct_id>
  </id_info>
  <brief_title>Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO)</brief_title>
  <acronym>PEVAR-PRO</acronym>
  <official_title>Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <brief_summary>
    <textblock>
      Purpose of the study is the evaluation of the applicability of the percutaneous technique&#xD;
      through double Proglide and Pre-Close Technique to the treatment of complex aortic aneurysms&#xD;
      with thoracic endoprosthesis (TEVAR), fenestrated or branched (F / B-EVAR) in which&#xD;
      patient-related factors, the devices used or the procedure, could affect the performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endovascular treatment using a percutaneous technique (Percutaneous Endovascular Aneurism&#xD;
      Repair - P-EVAR) has been used with increasing frequency to treat aortic aneurysms by&#xD;
      reducing operative times, postoperative pain and length of stay, compared to treatment by&#xD;
      surgical femoral access. During EVAR procedures, two accesses to the femoral arteries are&#xD;
      required to introduce the necessary tools for the stentgraft implantation. Such accesses can&#xD;
      be classically obtained by surgical incision, isolation of the common femoral arteries and&#xD;
      direct introduction of the devices.&#xD;
&#xD;
      Alternatively, the most modern approach involves direct puncture of the artery (without the&#xD;
      need for incision), through the skin and closure of the arterial breach through prolonged&#xD;
      manual compression of the vascular closure or systems (Vascular Closure Devices - VCD)&#xD;
      specifically designed. Among the various closure devices one of the most used and studied is&#xD;
      the Perclose Proglide (Abbott Vascular, Santa Clara CA, USA) that allows to affix a&#xD;
      polypropylene stitch to close the arterial breach. When closing high-caliber accesses (&gt; 8&#xD;
      French) it is necessary to use two devices that must be positioned before inserting the&#xD;
      introducer (&quot;Pre-Close Technique&quot;).&#xD;
&#xD;
      Few studies have so far evaluated the application of this method to the treatment of complex&#xD;
      cases such as thoracic or thoracoabdominal aortic aneurysms that requiring the use of high&#xD;
      caliber introducers.&#xD;
&#xD;
      The objective of the study is the evaluation of the technical success and clinical outcomes&#xD;
      of the PEVAR technique with a double vascular suture device Perclose ProGlide (Abbott&#xD;
      Illinois, U.S.A.).Endovascular treatment using a percutaneous technique (Percutaneous&#xD;
      Endovascular Aneurism Repair - P-EVAR) has been used with increasing frequency to treat&#xD;
      aortic aneurysms by reducing operative times, postoperative pain and length of stay, compared&#xD;
      to treatment by surgical femoral access. During EVAR procedures, two accesses to the femoral&#xD;
      arteries are required to introduce the necessary tools for the stentgraft implantation. Such&#xD;
      accesses can be classically obtained by surgical incision, isolation of the common femoral&#xD;
      arteries and direct introduction of the devices.&#xD;
&#xD;
      Alternatively, the most modern approach involves direct puncture of the artery (without the&#xD;
      need for incision), through the skin and closure of the arterial breach through prolonged&#xD;
      manual compression of the vascular closure or systems (Vascular Closure Devices - VCD)&#xD;
      specifically designed. Among the various closure devices one of the most used and studied is&#xD;
      the Perclose Proglide (Abbott Vascular, Santa Clara CA, USA) that allows to affix a&#xD;
      polypropylene stitch to close the arterial breach. When closing high-caliber accesses (&gt; 8&#xD;
      French) it is necessary to use two devices that must be positioned before inserting the&#xD;
      introducer (&quot;Pre-Close Technique&quot;).&#xD;
&#xD;
      Few studies have so far evaluated the application of this method to the treatment of complex&#xD;
      cases such as thoracic or thoracoabdominal aortic aneurysms that requiring the use of high&#xD;
      caliber introducers.&#xD;
&#xD;
      The objective of the study is the evaluation of the technical success and clinical outcomes&#xD;
      of the PEVAR technique with a double vascular suture device Perclose ProGlide (Abbott&#xD;
      Illinois, U.S.A.).&#xD;
&#xD;
      This is a retrospective observational study (320 cases treated in San Raffaele hospital in&#xD;
      Milan, during the period: October 2015 - 31 December 2019).&#xD;
&#xD;
      The chronology of the assessments will include:&#xD;
&#xD;
        -  An immediate evaluation at the end of the procedure by performing the ecocolordoppler&#xD;
           examination of the percutaneous accesses performed (as per routine). On the basis of&#xD;
           longitudinal and sagittal scans of the vessel, the Physician must check the presence of&#xD;
           the above complications that could be considered as &quot;failure&quot; of percutaneous access. In&#xD;
           the event that these complications are clinically evident (eg uncontrollable bleeding&#xD;
           from the puncture site), in the interest of a prompt management of the surgical problem,&#xD;
           it will not be necessary to perform an ecocolordoppler examination and the outcome will&#xD;
           be assigned &quot;failure &quot;.&#xD;
&#xD;
        -  A second echocolordoppler assessment performed on the first postoperative day (as per&#xD;
           routine) The study will be conducted in accordance with the ethical principles deriving&#xD;
           from the Helsinki Declaration and the current legislation on Observational Studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2019</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>technical success</measure>
    <time_frame>during the surgery</time_frame>
    <description>Use of femoral artery access in endovascular repair of aortic aneurysm (time frame between 2015 and 2020)&#xD;
Endovascular procedure: TEVAR - EVAR - B/FEVAR&#xD;
Side of femoral access: right- left&#xD;
Employment of downsizing on the femoral access: yes - no, as reported on patients' charts and operative report&#xD;
Size of percutaneous access sheath employed measured in French - Fr&#xD;
Number of percutaneous access vessel closure devices employed&#xD;
Access closure specific outcome: success - failure, as reported on patients' charts and operative report&#xD;
Cause of failure: hemorrhagic - occlusive, as reported on patients' charts and operative report</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>minor complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Femoral access vascular anatomy and patient's characteristics (time frame between 2015 and 2020):&#xD;
Previous surgical access to ipsilateral femoral artery: yes - no&#xD;
Previous deployment of percutaneous vascular closure devices to ipsilateral femoral artery: yes - no&#xD;
Diameter of femoral artery measured in millimiters (mm)&#xD;
Presence of calcification at access site: less or equal to1/3 of circumference - between 1/3 (excluded) and 2/3 (included) - more than 2/3 as measured on preoperative CT scan&#xD;
Localization of calcification: anterior - posterior - circumferential - lateral&#xD;
Body mass index reported as bare number defined as weight (kg)/height^2(m^2)</description>
  </secondary_outcome>
  <enrollment type="Actual">320</enrollment>
  <condition>Aneurysm</condition>
  <condition>Aneurysm Abdominal</condition>
  <condition>Aneurysm Thoracic</condition>
  <condition>Aneurysm, Thoracoabdominal Aortic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        a sample of 320 subjects will be analyzed (considering the cases treated in the period:&#xD;
        October 2015 - 31 december 2019).&#xD;
&#xD;
        The analysis of the retrospective data, will be based on the consultation of the archive of&#xD;
        the individual treated patients, present on software platform belonging to the San Raffaele&#xD;
        Hospital Information System) as well as the medical records.&#xD;
&#xD;
        An informatic database will be set up for the exclusive use of investigators. The data will&#xD;
        be analyzed subsequently through the application of descriptive and inferential statistics&#xD;
        techniques.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients aged â‰¥ 18 years, belonging to the Operative Unit of Vascular Surgery of&#xD;
             the San Raffaele Hospital,&#xD;
&#xD;
          -  patients candidates for endovascular treatment for thoracic, thoracoabdominal or&#xD;
             abdominal aortic pathologies.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - There are no criteria for exclusion of subjects from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 12, 2017</study_first_submitted>
  <study_first_submitted_qc>March 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2018</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Bertoglio Luca</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

